Preliminary clinical evaluation of glybenclamide in treatment of diabetes mellitus.
D000469:Alkaline Phosphatase / Q000032:analysis; D001663:Bilirubin / Q000652:urine; D001772:Blood Cell Count; D001786:Blood Glucose; D001799:Blood Sedimentation; D001806:Blood Urea Nitrogen; D002747:Chlorpropamide / Q000494:pharmacology; D002986:Clinical Trials as Topic; D003404:Creatinine / Q000652:urine; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007328:Insulin / Q000097:blood; D008297:Male; D011517:Prothrombin Time; D000637:Transaminases / Q000378:metabolism; D014280:Triglycerides / Q000652:urine
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D014280:Triglycerides; D003404:Creatinine; D000637:Transaminases; D000469:Alkaline Phosphatase; D001663:Bilirubin; D002747:Chlorpropamide